Clinical significance of serum thioredoxin 1 levels in patients with acute pancreatitis
Clinical significance of serum thioredoxin 1 levels in patients with acute pancreatitis
复制标题
DOI:
10.1097/01.mpa.0000203958.93758.bd
复制
发表时间:
2006-04-01
期刊:
影响因子:
2.9
通讯作者:
Chiba, Tsutomu
中科院分区:
文献类型:
--
作者:
Ohashi, Shinya;Nishio, Akiyoshi;Chiba, Tsutomu
Objective: Thioredoxin 1 (TRX-1), a redox-regulating protein with antioxidant activity, is induced by oxidative stress, and serum TRX-1 levels are recognized as an oxidative-stress marker. The aim of this study was to clarify the clinical significance of serum TRX-1 levels in patients with acute pancreatitis (AP) and evaluate the usefulness of this measurement in assessing disease severity.Methods: Serum TRX-1 levels were determined on admission in 18 patients with severe AP and 36 patients with mild AP. We also investigated the relationship between serum TRX-1 levels and clinical and laboratory data.Results: The median serum TRX-1 levels on admission were 54.9 ng/mL in mild AP and 118.8 ng/mL in severe AP. When the cutoff value for TRX-1 in predicting severe AP was determined to be 100 ng/mL, its sensitivity, specificity, and accuracy were 83.3%, 94.4%, and 90.7%, respectively. A significant correlation was observed between serum TRX-1 levels and Ranson score (r = 0.674), C-reactive protein (r = 0.718), interieukin 6 (r = 0.712) leukocyte count (r = 0.642), and serum amylase (r = 0.436).Conclusions: Serum TRX-1 levels significantly correlate with AP severity. TRX-1 should constitute a reliable oxidative-stress marker for the evaluation of AP severity in relation to oxidative stress.